Journal article
Rapamycin in ischemic stroke: Old drug, new tricks?
- Abstract:
-
The significant morbidity that accompanies stroke makes it one of the world's most devastating neurological disorders. Currently, proven effective therapies have been limited to thrombolysis and thrombectomy. The window for the administration of these therapies is narrow, hampered by the necessity of rapidly imaging patients. A therapy that could extend this window by protecting neurons may improve outcome. Endogenous neuroprotection has been shown to be, in part, due to changes in mTOR signa...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
+ Oxford University
More from this funder
Funding agency for:
Hadley, G
Grant:
Clinical Academic Graduate School
+ Medical Research Council
More from this funder
Funding agency for:
Adriaanse, B
Grant:
MR/M022757/1
+ Medical Research Council
More from this funder
Funding agency for:
Sutherland, B
Grant:
APP1137776
Expand funders...
Bibliographic Details
- Publisher:
- SAGE Publications Publisher's website
- Journal:
- Journal of Cerebral Blood Flow and Metabolism Journal website
- Volume:
- 39
- Issue:
- 1
- Pages:
- 20-35
- Publication date:
- 2018-10-18
- Acceptance date:
- 2018-09-06
- DOI:
- EISSN:
-
1559-7016
- ISSN:
-
0271-678X
- Source identifiers:
-
924499
Item Description
- Keywords:
- Pubs id:
-
pubs:924499
- UUID:
-
uuid:e9918f20-4a90-424d-bd32-a7910a8ae045
- Local pid:
- pubs:924499
- Deposit date:
- 2018-10-08
Terms of use
- Copyright holder:
- Hadley et al
- Copyright date:
- 2018
- Notes:
- © Author(s) 2018. This is the accepted manuscript version of the article. The final version is available online from SAGE Publications at: https://doi.org/10.1177/0271678X18807309
If you are the owner of this record, you can report an update to it here: Report update to this record